Home 2018

Archives

acute myeloid leukaemia

CD33-directed therapy: Current and future perspectives on targeted therapy in acute myeloid leukaemia (AML)

Mohammed Gbadamosi and Jatinder K Lamba from Department of Pharmacotherapy and Translational Research at the University of Florida explain CD33-directed therapy for acute myeloid leukaemia (AML), focussing on current and future perspectives
metabolomics studies

Acute myeloid leukaemia (AML) research and application

The current state of metabolomics research and application in Acute Myeloid Leukaemia is placed under the spotlight by Bradley Stockard and Jatinder Lamba from Department of Pharmacotherapy and Translational Research, University of Florida

Personalising antibody directed therapy in Acute Myeloid Leukaemia (AML)

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research explores the current progress in Acute Myeloid Leukaemia (AML)

Follow Us

Advertisements